{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:16:32Z","timestamp":1793024192731,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016802","name":"Natural Science Foundation of Changzhou Municipality","doi-asserted-by":"publisher","award":["CJ20245033"],"award-info":[{"award-number":["CJ20245033"]}],"id":[{"id":"10.13039\/100016802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016802","name":"Natural Science Foundation of Changzhou Municipality","doi-asserted-by":"publisher","award":["CJ20230075"],"award-info":[{"award-number":["CJ20230075"]}],"id":[{"id":"10.13039\/100016802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016802","name":"Natural Science Foundation of Changzhou Municipality","doi-asserted-by":"publisher","award":["CJ20220226"],"award-info":[{"award-number":["CJ20220226"]}],"id":[{"id":"10.13039\/100016802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03759-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:04:16Z","timestamp":1741856656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3675-3464","authenticated-orcid":false,"given":"Shuo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieru","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"6","key":"3759_CR1","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, et al. Global prevalence of nonalcoholic fatty liver disease: an updated review Meta-Analysis comprising a population of 78 million from 38 countries. Arch Med Res. 2024;55(6):103043.","journal-title":"Arch Med Res"},{"issue":"4","key":"3759_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (MASLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"6","key":"3759_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"issue":"6","key":"3759_CR4","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China. Hepatology. 2014;60(6):2099\u2013108.","journal-title":"Hepatology"},{"issue":"5","key":"3759_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, et al. Epidemiological features of MASLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364.","journal-title":"Hepatology"},{"issue":"7","key":"3759_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of MASLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"1 Suppl","key":"3759_CR7","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. MASLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"issue":"Suppl","key":"3759_CR8","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","volume":"29","author":"C Gofton","year":"2023","unstructured":"Gofton C, Upendran Y, Zheng MH, et al. MASLD: how is it different from MASLD? Clin Mol Hepatol. 2023;29(Suppl):S17\u201331.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"3759_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jhep.2023.01.024","volume":"78","author":"E Lee","year":"2023","unstructured":"Lee E, Korf H, Vidal-Puig. A an adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023;78(5):1048\u201362.","journal-title":"J Hepatol"},{"key":"3759_CR10","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238.","journal-title":"Mol Metab"},{"key":"3759_CR11","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.plipres.2021.101109","volume":"83","author":"H Li","year":"2021","unstructured":"Li H, Yu XH, Ou X, et al. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res. 2021;83:101109.","journal-title":"Prog Lipid Res"},{"issue":"8","key":"3759_CR12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/01.ATV.16.8.1040","volume":"16","author":"WH Capell","year":"1996","unstructured":"Capell WH, Zambon A, Austin MA, et al. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol. 1996;16(8):1040\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"3759_CR13","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1161\/hc4401.098490","volume":"104","author":"AC St-Pierre","year":"2001","unstructured":"St-Pierre AC, Ruel IL, Cantin B, et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation. 2001;104(19):2295\u20139.","journal-title":"Circulation"},{"issue":"17","key":"3759_CR14","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","volume":"75","author":"EK Duran","year":"2020","unstructured":"Duran EK, Aday AW, Cook NR, et al. Triglyceride-Rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease. J Am Coll Cardiol. 2020;75(17):2122\u201335.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3759_CR15","first-page":"576","volume":"55","author":"X Ma","year":"2024","unstructured":"Ma X, Wang Q, Hu X, et al. Association of sdLDL-C with incident carotid plaques with stable and vulnerable morphology: A prospective cohort study. Stroke. 2024;55(3):576\u201385.","journal-title":"Stroke"},{"issue":"10","key":"3759_CR16","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.cgh.2020.09.039","volume":"19","author":"S Patel","year":"2021","unstructured":"Patel S, Siddiqui MB, Roman JH, et al. Association between lipoprotein particles and atherosclerotic events in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2021;19(10):2202\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3759_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","volume":"13","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui MS, Fuchs M, Idowu MO, et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin Gastroenterol Hepatol. 2015;13(5):1000\u2013e10081003.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"3759_CR18","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/clinchem\/hvab048","volume":"67","author":"M Sampson","year":"2021","unstructured":"Sampson M, Wolska A, Warnick R, et al. A new equation based on the standard lipid panel for calculating small dense Low-Density Lipoprotein-Cholesterol and its use as a Risk-Enhancer test. Clin Chem. 2021;67(7):987\u201397.","journal-title":"Clin Chem"},{"issue":"8","key":"3759_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong VW, Adams LA, de Ledinghen V, et al. Noninvasive biomarkers in MASLD and NASH - current progress and future promise. Nat Rev Gastroenterol Hepatol. 2018;15(8):461\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3759_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in MASLD. Nat Rev Endocrinol. 2022;18(1):55\u201366.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"3759_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"issue":"2","key":"3759_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3350\/cmh.2019.0001n","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wong GL, Wong VW. Application of transient elastography in nonalcoholic fatty liver disease. Clin Mol Hepatol. 2020;26(2):128\u201341.","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"3759_CR23","first-page":"418","volume":"32","author":"Chinese Society of Hepatology, Chinese Medical Association","year":"2024","unstructured":"Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024). Zhonghua Gan Zang Bing Za Zhi. 2024;32(5):418\u201334.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"3759_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","volume":"5","author":"PN Newsome","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, et al. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020;5(4):362\u201373.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"3759_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","volume":"6","author":"D Petroff","year":"2021","unstructured":"Petroff D, Blank V, Newsome PN, et al. Assessment of hepatic steatosis by controlled Attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(3):185\u201398.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"3759_CR26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled Attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022\u201330.","journal-title":"J Hepatol"},{"issue":"3","key":"3759_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","volume":"31","author":"J Simon","year":"2020","unstructured":"Simon J, Nunez-Garcia M, Fernandez-Tussy P, et al. Targeting hepatic glutaminase 1 ameliorates Non-alcoholic steatohepatitis by restoring Very-Low-Density lipoprotein triglyceride assembly. Cell Metab. 2020;31(3):605\u2013e622610.","journal-title":"Cell Metab"},{"issue":"5","key":"3759_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343\u201351.","journal-title":"J Clin Invest"},{"issue":"12","key":"3759_CR29","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1111\/liv.15707","volume":"43","author":"RJ Klein","year":"2023","unstructured":"Klein RJ, Viana Rodriguez GM, Rotman Y, et al. Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated MASLD. Liver Int. 2023;43(12):2692\u2013700.","journal-title":"Liver Int"},{"key":"3759_CR30","unstructured":"Demant T, Packard C. In vivo studies of VLDL metabolism and LDL heterogeneity. Eur Heart J. 1998, 19 Suppl H:H7\u201310."},{"issue":"1","key":"3759_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5551\/jat.64271","volume":"31","author":"T Hirano","year":"2024","unstructured":"Hirano T, Satoh N, Ito Y. Specific increase in small dense Low-Density Lipoprotein-Cholesterol levels beyond triglycerides in patients with diabetes: implications for cardiovascular risk of MASLD. J Atheroscler Thromb. 2024;31(1):36\u201347.","journal-title":"J Atheroscler Thromb"},{"issue":"12","key":"3759_CR32","doi-asserted-by":"publisher","first-page":"e115403","DOI":"10.1371\/journal.pone.0115403","volume":"9","author":"K Imajo","year":"2014","unstructured":"Imajo K, Hyogo H, Yoneda M, et al. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. PLoS ONE. 2014;9(12):e115403.","journal-title":"PLoS ONE"},{"key":"3759_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2012.09.010","volume":"414","author":"S Hirayama","year":"2012","unstructured":"Hirayama S, Miida T. Small dense LDL: an emerging risk factor for cardiovascular disease. Clin Chim Acta. 2012;414:215\u201324.","journal-title":"Clin Chim Acta"},{"issue":"7","key":"3759_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/clinchem\/hvae061","volume":"70","author":"S Koba","year":"2024","unstructured":"Koba S, Satoh N, Ito Y, et al. Impact of direct measurement of small dense Low-Density lipoprotein cholesterol for Long-Term secondary prevention in patients with stable coronary artery disease. Clin Chem. 2024;70(7):957\u201366.","journal-title":"Clin Chem"},{"issue":"4","key":"3759_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/jdi.14133","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Xie J, Hou L, et al. Estimated small dense low-density lipoprotein cholesterol and nonalcoholic fatty liver disease in Nonobese populations. J Diabetes Investig. 2024;15(4):491\u20139.","journal-title":"J Diabetes Investig"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03759-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03759-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T20:47:35Z","timestamp":1741898855000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03759-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3759"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03759-5","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed guidelines outlined by the Helsinki Declaration and was approved by the Ethics Committee of Changzhou Third People\u2019s Hospital (02\u00a0A-A20230015). In addition, the Ethics Committee of Changzhou Third People\u2019s Hospital has waived informed consent for the current retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}